ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,222.68
      0.16%
      US Tech 100
      17,664.00
      0.13%
      Dow Jones
      39,512.84
      0.32%
      Brent Oil
      82.585
      -1.63%
      Bitcoin
      60,766.80
      -3.62%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Silo Pharma Inc (SILO)

      7. Silo Pharma Inc (SILO) News

      SILO Silo Pharma Inc

      1.68
      -0.08 (-4.55%)
      After Hours
      Last Updated: 17:16:11
      Delayed by 15 minutes
      Company Name Stock Ticker Symbol Market Type
      Silo Pharma Inc SILO NASDAQ Common Stock
        Price Change Change Percent Stock Price Last Traded
      Upgrade Icon
      -0.08 -4.55% 1.68 17:16:11
      Open Price Low Price High Price Close Price Prev Close
      1.711 1.67 1.76 1.68 1.76
      more quote information »

      Recent News

      Date Time Source Heading
      4/23/202408:15GLOBESilo Pharma Announces Positive Results for Intranasal PTSD..
      4/10/202408:11GLOBESilo Pharma set to Acquire Exclusive Licensing for Promising..
      3/20/202408:30GLOBESilo Pharma Exercises Option for Exclusive License Agreement..
      3/18/202407:15GLOBESilo Pharma Files Patent for Groundbreaking Ketamine Implant..
      2/28/202408:25GLOBESilo Pharma Completes Successful Dose-Ranging Study of..
      2/14/202408:45GLOBESilo Pharma’s SP-26 Ketamine Implant Demonstrates Successful..
      2/01/202413:15EDGAR2Form 8-K - Current report
      2/01/202410:00GLOBESilo Pharma Announces Pipeline Prioritization for 2024..
      1/31/202400:15EDGAR2Form EFFECT - Notice of Effectiveness
      1/25/202417:29EDGAR2Form S-3/A - Registration statement under Securities Act of..
      1/25/202417:27EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
      1/24/202408:55GLOBESilo Pharma Announces Positive Results in Alzheimer’s..
      1/23/202417:01EDGAR2Form S-3 - Registration statement under Securities Act of..
      1/11/202412:15EDGAR2Form 8-K/A - Current report: [Amend]
      1/09/202416:30EDGAR2Form 8-K - Current report
      1/04/202408:55GLOBESilo Pharma Successfully Completes First Phase of..
      12/28/202308:25GLOBESilo Pharma and Partner Receive Regulatory Approval to Begin..
      12/21/202316:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      12/20/202316:58EDGAR2Form 8-K12B - Notification that a class of securities of..
      12/18/202319:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      12/11/202316:05EDGAR2Form 8-K - Current report
      12/07/202318:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      12/05/202316:05EDGAR2Form 8-K - Current report
      12/04/202316:55EDGAR2Form 8-K - Current report
      11/30/202321:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      11/27/202317:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      11/22/202316:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      11/21/202308:01GLOBESilo Pharma Enters into Exclusive License Agreement with..
      11/20/202319:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      11/13/202317:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
      11/08/202308:11GLOBESilo Pharma to Initiate Dose-Ranging Study of Novel..
      10/23/202317:01EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
      10/23/202317:00EDGAR2Form DEF 14A - Other definitive proxy statements
      10/16/202308:11GLOBESilo Pharma’s SPU-21 Peptide Shows Positive Results Against..
      10/11/202308:35GLOBESilo Pharma Initiates Human Factor Study of SPC-15 for the..
      10/10/202316:00EDGAR2Form PRE 14A - Other preliminary proxy statements
      9/20/202308:28GLOBESilo Pharma Announces Positive Data on SPC-15 for PTSD and..
      9/12/202308:50GLOBESilo Pharma Initiates Feasibility Study of SPC-15 Novel..
      8/31/202307:30EDGAR2Form 8-K - Current report
      8/11/202316:50EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
      8/10/202308:50GLOBESilo Pharma Engages Clarivate for Intellectual Property and..
      8/08/202308:30GLOBESilo Pharma Reaches Positive Milestone with Nasal..
      6/29/202316:31EDGAR2Form 8-K - Current report
      6/21/202309:00GLOBESilo Pharma’s SPU-21 Treatment for Autoimmune Disease..
      6/13/202308:05GLOBESilo Pharma Signs Agreement to Develop First-in-Class..
      6/02/202308:50GLOBESilo Pharma Announces Participation on Webull Corporate..
      5/30/202309:00GLOBESilo Pharma Commences Study of Novel Joint Homing Peptide..

      Your Recent History

      NASDAQ
      SILO
      Silo Pharma
      NYSE
      DSL
      DoubleLine Income Soluti...
      Delayed Upgrade Clock